FindTrial
Sign In

Heart problem in liver disease and its effect after living donor liver transplant

Prevalence of cirrhotic cardiomyopathy and its implications in patients undergoing living donor liver transplantation - A prospective observational study - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/12/098349
Enrollment
200
Registered
2025-12-03
Start date
Unknown
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K77- Liver disorders in diseases classified elsewhere

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil Intervention3: Nil: Nil

Sponsors

Dr Mohamed Rela
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All patients between 18 to 65 years of age who are undergoing living donor liver transplant surgery at our institution

Exclusion criteria

Exclusion criteria: Patient refusal Diagnosed with known cardiac disease - ischaemic heart disease, valvular or structural heart disease Acute liver failure Chronic kidney disease

Design outcomes

Primary

MeasureTime frame
Will assess the status of cirrhotic cardiomyopathy during peri operative periodTimepoint: 1 week, 3 months and 6 months—

Secondary

MeasureTime frame
Will analyse any other cardiac eventsTimepoint: 1 week, 3 month & 6 months—

Countries

India

Contacts

Public ContactNisha Maharu M G

Dr. Rela Institute and Medical centre

nishamaharu@gmail.com09994107950

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026